These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 34412446)

  • 1. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lockdowns and the COVID-19 pandemic: What is the endgame?
    Lytras T; Tsiodras S
    Scand J Public Health; 2021 Feb; 49(1):37-40. PubMed ID: 32981448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
    Chun JY; Jeong H; Kim Y
    J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    Kwok KO; McNeil EB; Tsoi MTF; Wei VWI; Wong SYS; Tang JWT
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34118274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
    Kouamou V; Matarise R; Santos ED; Elose N; Manasa J
    Pan Afr Med J; 2021; 39():255. PubMed ID: 34707756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications.
    Jung J
    J Korean Med Sci; 2021 Feb; 36(7):e59. PubMed ID: 33619920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
    Chen JM; Sun YX; Chen JW
    J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 pandemic and vaccination build herd immunity.
    Redwan EM
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):577-579. PubMed ID: 33577008
    [No Abstract]   [Full Text] [Related]  

  • 12. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Daher-Nashif S; Al-Anany R; Ali M; Erradi K; Farag E; Abdallah AM; Emara MM
    Arch Virol; 2022 Sep; 167(9):1773-1783. PubMed ID: 35723757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding South Korea's Response to the COVID-19 Outbreak: A Real-Time Analysis.
    Jeong E; Hagose M; Jung H; Ki M; Flahault A
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33371309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of interventions against COVID-19: From lockdown to vaccination.
    Thompson J; Wattam S
    PLoS One; 2021; 16(12):e0261330. PubMed ID: 34919576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information and General Guidance for Healthcare Professionals in the Fourth Wave of COVID-19.
    Kim JI; Yu M; Yu S; Park JH
    J Korean Acad Nurs; 2021 Aug; 51(4):395-407. PubMed ID: 34497249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 - St. Louis, Missouri, January-May 2021.
    Rebmann T; Loux TM; Arnold LD; Charney R; Horton D; Gomel A
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1245-1248. PubMed ID: 34499631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Digital Tools to Mitigate the COVID-19 Pandemic: Comparative Retrospective Study of Six Countries.
    Zeng K; Bernardo SN; Havins WE
    JMIR Public Health Surveill; 2020 Dec; 6(4):e24598. PubMed ID: 33302255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.